10-Hydroxydecanoic Acid Potentially Elicits Antigen-Specific IgA Responses.


Journal

Biological & pharmaceutical bulletin
ISSN: 1347-5215
Titre abrégé: Biol Pharm Bull
Pays: Japan
ID NLM: 9311984

Informations de publication

Date de publication:
2020
Historique:
entrez: 4 8 2020
pubmed: 4 8 2020
medline: 1 6 2021
Statut: ppublish

Résumé

The effective antigen (Ag) uptake by microfold cells (M-cells) is important for the induction of an efficient mucosal immune responses. Here, we show that 10-hydroxydecanoic acid (10-HDAA) from royal jelly (RJ) potentially supports M-cell differentiation and induces effective antigen-specific mucosal immune responses in cynomolgus macaques. 10-HDAA increases the expression level of receptor activator of nuclear factor-kappaB (NF-κB) (RANK) in Caco-2 cells, which suggests that 10-HDAA potentially prompts the differentiation of Caco-2 cells into M-cells and increased transcytosis efficiency. This idea is supported by the following observations. Intranasal administration of 10-HDAA increased the number of M-cells in the epithelium overlying nasopharynx-associated lymphoid tissue (NALT) in macaques. Oral administration of 10-HDAA increased the number of M-cells in the follicle-associated epithelium (FAE) covering Peyer's patches (PPs) and significantly increased the antigen-specific immunoglobulin A (IgA) level in macaques. These findings suggest that the exogenous honeybee-derived medium-chain fatty acid 10-HDAA may effectively enhance antigen-specific immune responses.

Identifiants

pubmed: 32741940
doi: 10.1248/bpb.b20-00101
doi:

Substances chimiques

10-hydroxydecanoic acid 0
Antigens 0
Decanoic Acids 0
Immunoglobulin A 0
RANK Ligand 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1202-1209

Auteurs

Tatsuya Isayama (T)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Hikaru Etoh (H)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Naoki Kishimoto (N)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Toshimasa Takasaki (T)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Ayumi Kuratani (A)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Tomoki Ikuta (T)

Institute for Bee Products and Health Science, Yamada Bee Company, Inc.

Tomoki Tatefuji (T)

Institute for Bee Products and Health Science, Yamada Bee Company, Inc.

Nobutoki Takamune (N)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Atsunobu Muneoka (A)

Shin Nippon Biomedical Laboratories, Ltd.

Yoshihiro Takahashi (Y)

Shin Nippon Biomedical Laboratories, Ltd.

Shogo Misumi (S)

Department of Environmental and Molecular Health Sciences, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH